Promore Pharma’s strategy is to initiate partnering discussions for development programs once they have achieved clinical proof of concept. Targeted partners are mid to large-size pharmaceutical companies. Promore Pharma also evaluates other strategic partnering opportunities as they occur, and welcomes interest from potential partners in any ongoing project.
Promore Pharma AB
Promore Pharma is a privately held clinical-stage biopharmaceutical company developing state-of-the-art products, based on therapeutic peptides, for local or topical treatment of infections and wounds.
